Allevi Made the MedTech FierceMedTech’s 2018 Fierce 15
By nicolematthesen | February 20, 2019 | Health
These are the ideas that can move the needle.
FierceMedTech’s Fierce 15 class of 2018 is aimed at advancement—whether it’s simply combining new know-how with old methods, making definitive improvements in well-trodden fields, or pushing us to reconsider how far we can reach with the means available today.
They are about taking steps over, around or through what many have accepted as the limits of current medical technology, in order to make tangible impacts on patients’ lives, or the development of therapies that will.
Allevi:
Building the promise of 3D bioprinting for medical research.
CEO: Ricky Solorzano
Based: Philadelphia
Founded: 2015
The scoop: Allevi is looking to make good on the promise of desktop 3D bioprinting, with a focus on it becoming a real, affordable technology by offering three-dimensional tissue construction using any bioink.
What makes Allevi fierce: Being able to use 3D printing technology in medical research is one of the most promising, and most futuristic, elements of the medtech industry. Printing organs for human use, or for researchers to be able to test new medicines more safely, is the kind of thing that was only fit for the annals of 1950s pulp sci-fi.
Read the full article and list here.